Mark Copley

Optimization of an In Vitro Dissolution Test Method for Inhalation Formulations

Yoen-Ju Son, Michelle Horng, Mark Copley et al. · Dissolution Technologies · 2010 · 74 citations · Full text

Effect of Sampling Volume on Dry Powder Inhaler (DPI)-Emitted Aerosol Aerodynamic Particle Size Distributions (APSDs) Measured by the Next-Generation Pharmaceutical Impactor (NGI) and the Andersen Eight-Stage Cascade Impactor (ACI)

Hlack Mohammed, Daryl L. Roberts, Mark Copley et al. · AAPS PharmSciTech · 2012 · 42 citations · Full text

Aerosol Transport, Lung Deposition, Aerosol Sampling +4

Adapting the Abbreviated Impactor Measurement (AIM) Concept to Make Appropriate Inhaler Aerosol Measurements to Compare with Clinical Data: A Scoping Study with the “Alberta” Idealized Throat (AIT) Inlet

Jolyon P. Mitchell, Mark Copley, Yvonne Sizer et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2012 · 26 citations

Investigation of Dry Powder Inhaler (DPI) Resistance and Aerosol Dispersion Timing on Emitted Aerosol Aerodynamic Particle Sizing by Multistage Cascade Impactor when Sampled Volume Is Reduced from Compendial Value of 4 L

Hlack Mohammed, Jan Arp, Frank Chambers et al. · AAPS PharmSciTech · 2014 · 12 citations

Engineering, Aerosol Transport, Aerosol Formation +7

Laboratory Performance Testing of Aqueous Nasal Inhalation Products for Droplet/Particle Size Distribution: an Assessment from the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS)

William H. Doub, Julie M. Suman, Mark Copley et al. · AAPS PharmSciTech · 2023 · 11 citations · Full text